Conclusion
In conclusion, our preliminary findings demonstrated local UC-MSCs treatment produced a favorable therapeutic outcome and had a good safety profile in patients with pfCD for longer than 24 weeks. Randomized controlled trials involving larger clinical samples are warranted to assess the generalizability of our findings. Also, more mechanical studies are needed to deepen our understanding of this promising therapy.